Topics
October 2014 | Cover Stories
Applications for Neuroprotection: The Next Therapeutic Category in Retina Medicine
Pravin U. Dugel, MD
November/December 2013 | Cover Stories
Enabling Personalized Medicine in the Management of Uveal Melanoma
The value of a repository for tumor biopsy specimens after gene expression profiling.
Thomas M. Aaberg Jr, MD
June 19, 2026
Lexitas Pharma Services Named Octane Preferred Advisor
Potential Drug Signals Linked to Wet AMD Identified in Integrative Analysis
Foundation Fighting Blindness Receives $1 Million Commitment to Advance Gene-Agnostic IRD Therapies
June 18, 2026
Ocular Therapeutix Aligns with FDA on Planned Axpaxli NDA Submission for Wet AMD
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Supported by Zeiss
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Free Print Subscription
Email Newsletter
Conference Calendar
